Treating the Coronavirus | Reducing the Odds of Developing Severe Disease
HTML-код
- Опубликовано: 2 сен 2021
- A promising treatment for #COVID19, now being prepared for major trials in the UK, the US and India, grows out of #research supported by the Medical Research Council over more than five decades, and dating back to the discovery of coronaviruses.
The work of MRC-supported researchers provided global leadership and world-leading research in clinical trial implementation, health data management, #vaccine development and genomic surveillance through sequencing from early 2020.
RECOVERY, the first and largest clinical trial for identifying treatments for COVID-19, currently has over 40,000 participants and 180 active sites across the world. It has investigated 10 potential treatments, and in its first year definitely ruled out four of these. The trial has saved an estimated 22,000 lives in the UK and one million lives worldwide through the early identification of dexamethasone, the first effective treatment for patients hospitalised with severe COVID-19.
Learn more ▶️www.ukri.org/about-us/mrc/
Let’s connect!
Twitter 🔗 / the_mrc
LinkedIn 🔗 / medical-research-council
RUclips 🔗 / medicalresearchcouncil
Instagram 🔗 / weareukri
We think you’ll like…
The Immune System | Preserving Disease Resistance After a Transplant
▶️ • The Immune System | Pr...
Kidney Perfusion | New Drug to Protect Kidneys From Immune System During Transplant
▶️ • Kidney Perfusion | New...
ABOUT THE MEDICAL RESEARCH COUNCIL (MRC)
The Medical Research Council (MRC) improves the health of people in the UK - and around the world - by supporting excellent science, and training the very best scientists.
Find out more ▶️ www.ukri.org/councils/MRC/
#MRC #Medicine #MedicalSciences #MedicalResearch #Innovation #Health 
Наука
IFNs, finally someone tackles this problem correctly. Hopefully they succeed.
Lots of literature to back up this approach and could be a game changer. This is translational science from lab to bedside done absolutely the right way!
Results due soon in our company's phase 3 and US activ 2/3
I sincerely hope this therapy will be available to patients ASAP
Results due imminent
Has the UK Govt secured supplies of this drug yet ? or are we one step behind the US Govt ? If this is given authorisation or Emergency use approval even , there will be a major shortage of supply as all countries fight for deliveries .
For the latest information on the government’s approach to COVID-19 vaccines and treatments, visit: www.gov.uk/drug-safety-update/covid-19-vaccines-and-medicines-updates-for-september-2021/
Sir Steven Holgate, is the man.
This is fantastic news
Results from phase3 due imminently
The World needs as much help as possible, Synairgen will help , I have NO Doubt this Drug will be approved SOON !!!
If the results are as good as phase 2 this share will rocket. News should be soon if we proceed to phase 3 in the US
@@pauloconnor5808 SNG was trialled in Newcastle RVI, Nurses were impressed.
Emergency use approval for #SNG001 can't come soon enough IMHO.
A great UK company. 👏👏 I eagerly await the results of its International P3 trials. How has it stayed under the radar for so long? An effective and reliable covid therapy will transform this pandemic.
When are results due
The clinical trials are being conducted by Synairgen with no current involvement from the MRC. To get the latest news about the progress of the trials, we would recommend visiting Synairgen’s website - www.synairgen.com/
Nice simplistic synopsis. When are the phase 3 results expected?
The clinical trials are being conducted by Synairgen with no current involvement from the MRC. For the latest updates, we would recommend that you visit Synairgen’s website - www.synairgen.com/